Spreadex Market Update

AstraZeneca weighs on FTSE, S&P Tiptoes Around 5K



Equities

Major US stock indices displayed a positive trend with the S&P 500 nearing the significant 5,000-point threshold. This upward movement was mirrored by gains in the Dow Jones Industrial Average and the Nasdaq Composite. The performance of these indices came as investors digested a mix of earnings reports and economic data, including a slight dip in US jobless claims.

The FTSE 100's trajectory was less favourable, where weakness was largely influenced by AstraZeneca's disappointing earnings announcement. The pharmaceutical giant saw its shares tumble by over 6%, closing at their lowest since October 2022, after fourth-quarter profits fell short of analysts' expectations. This was attributed to increased research and development expenses and price cuts for some medications in emerging markets, despite the company projecting strong growth in 2024.

In contrast, British American Tobacco enjoyed a surge in its share price, climbing 7.1% following news of its intentions to divest some of its stake in India's ITC. This move is part of a strategy to reduce debt and potentially resume share buybacks. Meanwhile, consumer goods behemoth Unilever reported a rise in fourth-quarter sales and announced a 1.5 billion euro share buyback programme, which resulted in a 3.2% increase in its share price.

In Asia, the Nikkei 225 surged to its highest level in 34 years, buoyed by dovish comments from the Bank of Japan, while China's stock indices also posted gains, welcoming leadership changes at the country's market regulator and digesting the latest consumer price index data.

Forex & Commodities

On Thursday, the US dollar appreciated following a report indicating a stronger-than-anticipated US labour market, suggesting a sustained economic resilience. This development further solidified the Federal Reserve's stance on maintaining current interest rates, with little indication of imminent cuts. Unemployment claims in the US for the week ending February 3 fell to 218,000, surpassing economists' expectations and underscoring the robustness of the labour market despite recent layoffs. This data, reinforcing the dollar's strength, pushed the dollar index up by 0.14% to 104.16.

The British pound experienced a slight decline of 0.11% against the dollar, trading at $1.2613. In the currency markets, the yen also weakened against the dollar, declining by approximately 0.82% to 149.380, influenced by the Bank of Japan's Deputy Governor's remarks on the unlikelihood of aggressive interest rate hikes.

Gold prices dipped marginally by 0.13% to $2,031.58 per ounce, influenced by the strengthening dollar and rising bond yields, which dampened the appeal of the non-yielding asset. Palladium extended its losses, touching a five-year low, amid concerns over long-term demand and comparisons with platinum prices, which have historically been higher.

Oil prices witnessed a significant increase of over 3% following geopolitical tensions in the Middle East and a stronger-than-expected drawdown in US fuel stocks. Brent futures escalated by 3% to $81.36 a barrel, and West Texas Intermediate crude saw a 3.2% rise to $76.22, driven by the rejection of a ceasefire in Gaza by Israel and the impact of refinery maintenance in the US and diesel shortages in Europe.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.